Skip to content
Monday, July 7, 2025
Latest:
  • Cleveland Clinic 37th Annual Intensive Review of Internal Medicine 2025
  • Obesity Medicine Association Annual Conference Obesity Medicine 2025
  • UCSF 41st Annual Advances in Heart Disease 2024
  • Harvard The Blackburn Course in Obesity Medicine 2025
  • Harvard Gastroenterology 2025
Medicine Academy | USMLE & Board Videos

More results...

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
MENUMENU
  • REFUND POLICY
  • Specialities
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Endocrinology
    • Emergency Medicine
    • Gastroenterology
    • Family Medicine
    • Hematology
    • Infectious disease
    • Internal Medicine
    • Surgery
    • Neurology
    • Nephrology
    • Obstetrics and Gynecology
    • Rheumatology
    • Radiology
    • Oncology
    • Pathology
    • Pediatrics
    • Pulmonology
  • USMLE
    • Boards And Beyond
    • Doctors in Training
    • Draw it to know it
    • Kaplan
    • Lecturio
    • Medquest
    • Sketchy
  • Qbank
  • FAQ
  • How to Buy
  • Terms
BoardPathologyUSCAP

USCAP Myeloproliferative and Myelodysplastic Neoplasms: The Past, Present, and Future

November 8, 2024 admin

 

Course Description
In the era of the rapid development of new diagnostic modalities and novel targeted treatment options, a comprehensive diagnostic approach to myelodysplastic and myeloproliferative neoplasms becomes ever more critical. However, the rapidly evolving scientific and technological discoveries that have been continuously incorporated into the classification of myelodysplastic and/or myeloproliferative neoplasms significantly increase already complex hematopathology practice. (Hemato)pathologists are currently facing the following challenges:

  • How to stay abreast of this avalanche of data?
  • How to incorporate the data into my day-to-day practice?
  • What testing should I order to correctly classify myelodysplastic and myeloproliferative neoplasms?
  • How should my diagnosis be worded in the face of two new classifications of hematologic neoplasms (5th edition WHO and 2022 International Consensus Classifications).

This course, led by four experienced academic hematopathologists practicing at four large cancer centers, will answer all of these questions (and more) by reviewing cases of myeloid neoplasms with myelodysplastic and myeloproliferative features. Join us on the exciting journey from the past to the present and into the future!

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:

  • Become familiar with the changes to classification of myelodysplastic and myeloproliferative neoplasms and overlap myelodysplastic/myeloproliferative neoplasms.
  • Identify critical ancillary testing needed for accurate classification, as informed by the clinical scenario or morphologic findings.
  • Recognize morphologic and immunophenotypic correlates of underlying genetic lesions in MDS/MPN and related neoplasms.
  • Generate a comprehensive (and comprehensible), clinically relevant, integrated pathology report that includes the most updated classification systems.

Details : 8 MP4 + 7 PDF files

Price : $ 150

Buy

  • USCAP Crash Course in Cytopathology: Thorax, Soft Tissue, Head and Neck, Liver, Pancreatobiliary and Genitourinary Tract
  • USCAP Bone and Soft Tissue Pathology: Keep Calm and Navigate the Updates and Pitfalls

You May Also Like

Comprehensive Review of Breast Imaging 2022

May 17, 2022 admin

Mayo Clinic Internal Medicine Board Review 2022

October 13, 2022 admin

USCAP’s Focus on Diversity and Inclusion 2020

October 30, 2021 admin
Copyright © 2025 Medicine Academy | USMLE & Board Videos. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.